Free HAS-BLED Calculator

HAS‑BLED Score: A Bleeding Risk Assessment for Atrial Fibrillation

The HAS‑BLED score is a clinical scoring system that estimates the one‑year probability of major bleeding in individuals with atrial fibrillation (AF). Developed in 2010 by Professor Gregory Y.H. Lip and colleagues, the tool integrates nine discrete risk factors to produce a composite bleeding risk score. Among available bleeding risk scales, the HAS‑BLED criteria are considered more accurate at identifying patients at heightened risk of major hemorrhage, making it a cornerstone of anticoagulation risk assessment.

This bleeding risk calculator simplifies the scoring process: you simply select the factors that apply to your patient. The tool automatically tallies the points and provides an immediate interpretation along with clinical recommendations. It is important to note that, while this calculator delivers a systematic estimate, it does not replace the comprehensive evaluation performed by a healthcare professional.

Indications and Philosophy

The primary purpose of the HAS‑BLED score is to guide clinicians in the management of atrial fibrillation before starting anticoagulation therapy. The scale is not intended to exclude patients from prophylaxis; rather, it serves to flag those with a high bleeding potential so that they can be monitored more closely and potentially reversible risk factors can be addressed. As noted by its creator, the objective is to improve safety, not to withhold treatment.

The Nine Factors of the HAS‑BLED Scale

The acronym HAS‑BLED stands for the following criteria:

• Hypertension – uncontrolled blood pressure, specifically systolic >160 mmHg. Note that merely having a diagnosis of hypertension is not sufficient; it is the lack of control that increases risk.
• Abnormal renal function – chronic dialysis, renal transplant, or serum creatinine >200 µmol/L (2.26 mg/dL) with reduced estimated glomerular filtration rate (eGFR).
• Abnormal liver function – cirrhosis or biochemical evidence of significant liver injury (bilirubin >2× upper limit of normal or AST/ALT/AP >3× upper limit of normal).
• Stroke – a history of prior stroke.
• Bleeding – a history of major bleeding or a predisposition such as anemia or reduced hemoglobin.
• Labile INR – in patients on oral anticoagulants, an international normalized ratio (INR) that is outside the therapeutic range at least 40 % of the time (i.e., low time in therapeutic range).
• Elderly – age 65 years or older.
• Alcohol use – consumption of eight or more standard drinks per week.
• Drugs – concurrent use of medications that predispose to bleeding, including antiplatelet agents (aspirin, clopidogrel) and non‑steroidal anti‑inflammatory drugs (e.g., ibuprofen, diclofenac).

Each present factor adds one point to the total score. The maximum possible score is 9.

Interpreting the HAS‑BLED Score

The total score is interpreted as follows:

Score	Bleeding Risk Category	Clinical Suggestion
0	Low	Anticoagulation can be considered without special precautions.
1–2	Moderate	Anticoagulation is generally appropriate, but close monitoring is advisable.
≥3	High	Alternatives to standard anticoagulation should be weighed; potentially reversible risk factors should be addressed. Regular follow‑up and frequent INR checks are recommended.

The scale must be interpreted in the context of the entire clinical picture. A high score does not automatically contraindicate anticoagulation, but it signals the need for heightened vigilance and, where possible, correction of reversible elements.

Reversible Risk Factors

Several HAS‑BLED components can be modified or reversed, potentially lowering bleeding risk:

• Uncontrolled hypertension
• Predisposition to bleeding (e.g., treating anemia)
• Labile INR (improving anticoagulation control)
• Excessive alcohol consumption
• Concomitant use of other bleeding‑prone drugs

Definition of Major Bleeding

The HAS‑BLED score specifically estimates the risk of major bleeding, which is defined by the following criteria:

• Fatal bleeding.
• Clinically overt bleeding accompanied by a drop in hemoglobin of at least 20 g/L (1.24 mmol/L).
• Bleeding requiring transfusion of two or more units of packed red blood cells.
• Bleeding occurring in a critical anatomic site (e.g., intracranial, intraspinal, intraocular, retroperitoneal, pericardial, or non‑traumatic intra‑articular).

By flagging patients at high risk, the HAS‑BLED score enables targeted interventions and supports shared decision‑making between the clinician and the patient.